These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 24271659)

  • 1. Systematic review of protein biomarkers of invasive behavior in glioblastoma.
    Sayegh ET; Kaur G; Bloch O; Parsa AT
    Mol Neurobiol; 2014 Jun; 49(3):1212-44. PubMed ID: 24271659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
    J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Concomitant Radiochemotherapy on Invasion Potential of Glioblastoma.
    Hutóczki G; Bognár L; Tóth J; Scholtz B; Zahuczky G; Hanzély Z; Csősz É; Reményi-Puskár J; Kalló G; Hortobágyi T; Klekner A
    Pathol Oncol Res; 2016 Jan; 22(1):155-60. PubMed ID: 26450124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.
    Jovčevska I; Zupanec N; Kočevar N; Cesselli D; Podergajs N; Stokin CL; Myers MP; Muyldermans S; Ghassabeh GH; Motaln H; Ruaro ME; Bourkoula E; Turnšek TL; Komel R
    PLoS One; 2014; 9(11):e113688. PubMed ID: 25419715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic markers for glioblastoma.
    Jung CS; Unterberg AW; Hartmann C
    Histol Histopathol; 2011 Oct; 26(10):1327-41. PubMed ID: 21870336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TPD52L2 impacts proliferation, invasiveness and apoptosis of glioblastoma cells via modulation of wnt/β-catenin/snail signaling.
    Qiang Z; Jun-Jie L; Hai W; Hong L; Bing-Xi L; Lei C; Wei X; Ya-Wei L; Huang A; Song-Tao Q; Yun-Tao L
    Carcinogenesis; 2018 Feb; 39(2):214-224. PubMed ID: 29106517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
    Sun J; Zhao B; Du K; Liu P
    Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs as Multifaceted Players in Glioblastoma Multiforme.
    Mercatelli N; Galardi S; Ciafrè SA
    Int Rev Cell Mol Biol; 2017; 333():269-323. PubMed ID: 28729027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of CD147 in patients with glioblastoma.
    Yang M; Yuan Y; Zhang H; Yan M; Wang S; Feng F; Ji P; Li Y; Li B; Gao G; Zhao J; Wang L
    J Neurooncol; 2013 Oct; 115(1):19-26. PubMed ID: 23925827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance.
    Wu ZB; Cai L; Lin SJ; Xiong ZK; Lu JL; Mao Y; Yao Y; Zhou LF
    Neuro Oncol; 2013 Sep; 15(9):1264-75. PubMed ID: 23828241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
    Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
    Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma.
    Kruthika BS; Sugur H; Nandaki K; Arimappamagan A; Paturu K; Santosh V
    J Clin Pathol; 2019 Oct; 72(10):677-681. PubMed ID: 31270134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers and Immunotherapeutic Targets in Glioblastoma.
    Hung AL; Garzon-Muvdi T; Lim M
    World Neurosurg; 2017 Jun; 102():494-506. PubMed ID: 28300714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic Pathology.
    Campanella R; Guarnaccia L; Cordiglieri C; Trombetta E; Caroli M; Carrabba G; La Verde N; Rampini P; Gaudino C; Costa A; Luzzi S; Mantovani G; Locatelli M; Riboni L; Navone SE; Marfia G
    Cells; 2020 Jan; 9(2):. PubMed ID: 31991805
    [No Abstract]   [Full Text] [Related]  

  • 15. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
    Nana AW; Yang PM; Lin HY
    Asian Pac J Cancer Prev; 2015; 16(16):6813-23. PubMed ID: 26514451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma.
    Zhang N; Wei L; Ye M; Kang C; You H
    Front Immunol; 2020; 11():592612. PubMed ID: 33329578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients.
    Liu Y; Carlsson R; Ambjørn M; Hasan M; Badn W; Darabi A; Siesjö P; Issazadeh-Navikas S
    J Neurosci; 2013 Aug; 33(35):14231-45. PubMed ID: 23986257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms regulating glioma invasion.
    Paw I; Carpenter RC; Watabe K; Debinski W; Lo HW
    Cancer Lett; 2015 Jun; 362(1):1-7. PubMed ID: 25796440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
    Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
    J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.
    Nickel AC; Wan XY; Saban DV; Weng YL; Zhang S; Keyvani K; Sure U; Zhu Y
    J Neurooncol; 2019 Jan; 141(1):31-41. PubMed ID: 30392087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.